Antiepileptic medications in autism spectrum disorder

A systematic review and meta-analysis

Tomoya Hirota, Jeremy Veenstra-Vanderweele, Eric Hollander, Taro Kishi

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Electroencephalogram-recorded epileptiform activity is common in children with autism spectrum disorder (ASD), even without clinical seizures. A systematic literature search identified 7 randomized, placebo-controlled trials of antiepileptic drugs (AEDs) in ASD (total n = 171), including three of valproate, and one each of lamotrigine, levetiracetam, and topiramate. Meta-analysis revealed no significant difference between medication and placebo in four studies targeting irritability/agitation and three studies investigating global improvement, although limitations include lack of power and different medications with diverse actions. Across all seven studies, there was no significant difference in discontinuation rate between two groups. AEDs do not appear to have a large effect size to treat behavioral symptoms in ASD, but further research is needed, particularly in the subgroup of patients with epileptiform abnormalities.

Original languageEnglish (US)
Pages (from-to)948-957
Number of pages10
JournalJournal of Autism and Developmental Disorders
Volume44
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Anticonvulsants
Meta-Analysis
etiracetam
Placebos
Behavioral Symptoms
Valproic Acid
Electroencephalography
Seizures
Randomized Controlled Trials
Research
Autism Spectrum Disorder
Power (Psychology)
topiramate
lamotrigine

Keywords

  • Anticonvulsant
  • Antiepileptic
  • Autism
  • Mood stabilizer
  • Pervasive developmental disorder

ASJC Scopus subject areas

  • Developmental and Educational Psychology

Cite this

Antiepileptic medications in autism spectrum disorder : A systematic review and meta-analysis. / Hirota, Tomoya; Veenstra-Vanderweele, Jeremy; Hollander, Eric; Kishi, Taro.

In: Journal of Autism and Developmental Disorders, Vol. 44, No. 4, 2014, p. 948-957.

Research output: Contribution to journalArticle

Hirota, Tomoya ; Veenstra-Vanderweele, Jeremy ; Hollander, Eric ; Kishi, Taro. / Antiepileptic medications in autism spectrum disorder : A systematic review and meta-analysis. In: Journal of Autism and Developmental Disorders. 2014 ; Vol. 44, No. 4. pp. 948-957.
@article{bb52e6a03d054516936745f20a9fe9df,
title = "Antiepileptic medications in autism spectrum disorder: A systematic review and meta-analysis",
abstract = "Electroencephalogram-recorded epileptiform activity is common in children with autism spectrum disorder (ASD), even without clinical seizures. A systematic literature search identified 7 randomized, placebo-controlled trials of antiepileptic drugs (AEDs) in ASD (total n = 171), including three of valproate, and one each of lamotrigine, levetiracetam, and topiramate. Meta-analysis revealed no significant difference between medication and placebo in four studies targeting irritability/agitation and three studies investigating global improvement, although limitations include lack of power and different medications with diverse actions. Across all seven studies, there was no significant difference in discontinuation rate between two groups. AEDs do not appear to have a large effect size to treat behavioral symptoms in ASD, but further research is needed, particularly in the subgroup of patients with epileptiform abnormalities.",
keywords = "Anticonvulsant, Antiepileptic, Autism, Mood stabilizer, Pervasive developmental disorder",
author = "Tomoya Hirota and Jeremy Veenstra-Vanderweele and Eric Hollander and Taro Kishi",
year = "2014",
doi = "10.1007/s10803-013-1952-2",
language = "English (US)",
volume = "44",
pages = "948--957",
journal = "Journal of Autism and Developmental Disorders",
issn = "0162-3257",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Antiepileptic medications in autism spectrum disorder

T2 - A systematic review and meta-analysis

AU - Hirota, Tomoya

AU - Veenstra-Vanderweele, Jeremy

AU - Hollander, Eric

AU - Kishi, Taro

PY - 2014

Y1 - 2014

N2 - Electroencephalogram-recorded epileptiform activity is common in children with autism spectrum disorder (ASD), even without clinical seizures. A systematic literature search identified 7 randomized, placebo-controlled trials of antiepileptic drugs (AEDs) in ASD (total n = 171), including three of valproate, and one each of lamotrigine, levetiracetam, and topiramate. Meta-analysis revealed no significant difference between medication and placebo in four studies targeting irritability/agitation and three studies investigating global improvement, although limitations include lack of power and different medications with diverse actions. Across all seven studies, there was no significant difference in discontinuation rate between two groups. AEDs do not appear to have a large effect size to treat behavioral symptoms in ASD, but further research is needed, particularly in the subgroup of patients with epileptiform abnormalities.

AB - Electroencephalogram-recorded epileptiform activity is common in children with autism spectrum disorder (ASD), even without clinical seizures. A systematic literature search identified 7 randomized, placebo-controlled trials of antiepileptic drugs (AEDs) in ASD (total n = 171), including three of valproate, and one each of lamotrigine, levetiracetam, and topiramate. Meta-analysis revealed no significant difference between medication and placebo in four studies targeting irritability/agitation and three studies investigating global improvement, although limitations include lack of power and different medications with diverse actions. Across all seven studies, there was no significant difference in discontinuation rate between two groups. AEDs do not appear to have a large effect size to treat behavioral symptoms in ASD, but further research is needed, particularly in the subgroup of patients with epileptiform abnormalities.

KW - Anticonvulsant

KW - Antiepileptic

KW - Autism

KW - Mood stabilizer

KW - Pervasive developmental disorder

UR - http://www.scopus.com/inward/record.url?scp=84893273545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893273545&partnerID=8YFLogxK

U2 - 10.1007/s10803-013-1952-2

DO - 10.1007/s10803-013-1952-2

M3 - Article

VL - 44

SP - 948

EP - 957

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

SN - 0162-3257

IS - 4

ER -